Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| United States Department of Veterans Affairs | 4 | 2024 | 688 | 0.860 |
Why?
|
| Home Care Services | 1 | 2024 | 257 | 0.670 |
Why?
|
| Veterans | 4 | 2024 | 1486 | 0.650 |
Why?
|
| Self Care | 5 | 2021 | 387 | 0.610 |
Why?
|
| Qualitative Research | 1 | 2024 | 1455 | 0.510 |
Why?
|
| Transitional Care | 2 | 2024 | 42 | 0.390 |
Why?
|
| Heart Failure | 5 | 2023 | 2067 | 0.330 |
Why?
|
| Patient Discharge | 3 | 2024 | 916 | 0.270 |
Why?
|
| Acute Coronary Syndrome | 2 | 2021 | 279 | 0.260 |
Why?
|
| Hospitals, Veterans | 2 | 2024 | 255 | 0.250 |
Why?
|
| Medication Adherence | 2 | 2020 | 504 | 0.230 |
Why?
|
| Hospitals, Rural | 1 | 2024 | 44 | 0.210 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 156 | 0.180 |
Why?
|
| Social Support | 2 | 2024 | 625 | 0.180 |
Why?
|
| Continuity of Patient Care | 1 | 2024 | 281 | 0.180 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 41 | 0.180 |
Why?
|
| Interviews as Topic | 1 | 2024 | 803 | 0.170 |
Why?
|
| Psychometrics | 3 | 2019 | 727 | 0.170 |
Why?
|
| Smartphone | 1 | 2021 | 88 | 0.170 |
Why?
|
| United States | 8 | 2024 | 14938 | 0.160 |
Why?
|
| Work Schedule Tolerance | 1 | 2019 | 52 | 0.150 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 85 | 0.150 |
Why?
|
| Quality Indicators, Health Care | 1 | 2021 | 307 | 0.150 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2019 | 31 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 98 | 0.150 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2019 | 38 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2024 | 703 | 0.150 |
Why?
|
| Diuretics | 1 | 2019 | 72 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2021 | 178 | 0.140 |
Why?
|
| Medicaid | 1 | 2022 | 447 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2019 | 1805 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2019 | 137 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 695 | 0.130 |
Why?
|
| Aspirin | 1 | 2020 | 385 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 469 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 2116 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 505 | 0.120 |
Why?
|
| Perception | 1 | 2018 | 369 | 0.110 |
Why?
|
| Self Report | 1 | 2019 | 839 | 0.110 |
Why?
|
| Telemedicine | 2 | 2021 | 873 | 0.110 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 5520 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 33604 | 0.110 |
Why?
|
| Sleep | 1 | 2019 | 799 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2019 | 1739 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 5803 | 0.090 |
Why?
|
| Humans | 16 | 2024 | 138651 | 0.090 |
Why?
|
| Hypertension | 1 | 2019 | 1242 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1567 | 0.080 |
Why?
|
| Decision Making | 1 | 2018 | 948 | 0.080 |
Why?
|
| Male | 9 | 2024 | 68260 | 0.080 |
Why?
|
| Female | 9 | 2024 | 73763 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2490 | 0.080 |
Why?
|
| Aged | 7 | 2024 | 24024 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 2 | 2019 | 290 | 0.070 |
Why?
|
| Exercise | 1 | 2019 | 2072 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 3307 | 0.050 |
Why?
|
| Staff Development | 1 | 2024 | 58 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 1765 | 0.050 |
Why?
|
| Pandemics | 2 | 2023 | 1641 | 0.050 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2023 | 76 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 131 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2024 | 218 | 0.050 |
Why?
|
| Veterans Health | 1 | 2023 | 187 | 0.050 |
Why?
|
| Health Services Research | 1 | 2023 | 406 | 0.040 |
Why?
|
| Hospitalization | 2 | 2022 | 2235 | 0.040 |
Why?
|
| Economics, Behavioral | 1 | 2020 | 9 | 0.040 |
Why?
|
| Leadership | 1 | 2024 | 390 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2020 | 131 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5112 | 0.040 |
Why?
|
| Italy | 1 | 2019 | 109 | 0.040 |
Why?
|
| Sweden | 1 | 2019 | 99 | 0.040 |
Why?
|
| Adult | 4 | 2024 | 38201 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 319 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 23 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2022 | 575 | 0.030 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2018 | 43 | 0.030 |
Why?
|
| Hospitals | 1 | 2021 | 695 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1296 | 0.030 |
Why?
|
| Medicare | 1 | 2021 | 789 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 489 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3433 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 1341 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 2349 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 2844 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10252 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6851 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 7554 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 15909 | 0.010 |
Why?
|